FIG. 3.
Markers of proliferation are upregulated in nevi from patients with THRA mutations. (A) Hematoxylin and eosin staining and immunofluorescence for K17 and DIO3 (D3) were performed on sections from skin lesions of four different patients with THRA mutations. Magnification 20 × and 10 × . Scale bars represent 50 μm. (B) Expression of K17 and D3 in sections of normal human skin was evaluated by immunofluorescence. Magnification 10 × and 40 × . Scale bars represent 50 μm. Color images are available online.